On ECHEMI
Home > Drugs > Alpha-thalassemia in children
Alpha-thalassemia in children
Alpha thalassemia in children is a group of hemolytic anemias caused by the α-globin chain synthesis disorder due to the deletion or functional defect (point mutation) of the α-globin gene. It is a type of thalassemia. Thalassemia, also known as "thalassemia", is caused by the blockage or complete inhibition of the synthesis of one or more globin peptide chains, resulting in abnormal Hb composition and chronic hemolytic anemia. According to the different types of globin gene deletions or defects, the corresponding inhibition of globin chain synthesis is caused. Thalassemia can be divided into α-thalassemia, β-thalassemia, δ-thalassemia, γ-thalassemia and the rare β-thalassemia; the first two types are common. They are all autosomal incomplete dominant inheritance.
  • Site of disease:

    Blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    Children
  • Related symptoms:

    Skin bleeding spots hemolytic jaundice splenomegaly fetal edema physiological anemia in children
  • Concurrent disease:

Related Drugs
Deferoxamine Mesylate for Injection
Indication: Single iron chelates for the treatment of chronic iron overload, acute iron poisoning, aluminum overload in dialysis patients, and for the diagnosis of iron or aluminum overload.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.